Publication | Closed Access

Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027

Health SciencesAntimicrobial StewardshipC. Difficile AssayLow PrevalenceInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceEpidemiologyBd Max CdiffDiagnostic MicrobiologyDrug Resistance